world-cancer-2017-scientifictracks-abstracts

6 / 28

Page 28
Notes:
conferenceseries.com
Volume 9, Issue 9 (Suppl) J Cancer Sci Ther, an open access journal
ISSN: 1948-5956 World Cancer 2017
October 19-21, 2017
25th WORLD CANCER CONFERENCE
October 19-21, 2017 | Rome, Italy
Holism and stereotactic body radiation therapy
Mohammed Y Almaghrabi
King Abdullah Medical City, Saudi Arabia
Holism is a new concept dealing with Stereotactic Body Radiation Therapy (SBRT) settings. SBRT experts concern with
lessening organ toxicity. Use of DVH (dose-volume histogram) solely in SBRT treatment care plan/ protocols might
cause grave consequences if other factors ignored. Correlation between specific injury and radiation dose is still uncertain.
Sometimes there are discrepancies between studies in defining the injury. There is little known about most of the toxicity
mechanisms. Use of biologically equivalent dose model is still controversial. It seems inevitable that SBRT delivery, patient
factors (including comorbidities, patient's BMI, gender, habits, age, and ECOG PS score), tumor factors and treatment factors
should carefully be examined.
Biography
Mohammed Y Almaghrabi is a currently working as Radiation Oncologist at King Abdullah Medical City, Saudi Arabia. He is leading stereotactic radiosurgery/
stereotactic body radiation therapy task groups at the same hospital. He was Head of Radiation Oncology department at Prince Faisal Cancer Centre, Saudi Arabia.
He has his research experience from University of Ottawa Canada and Nantes University, France. He has been a recipient of many awards and grants. He was
selected as a Sectional Editor (Radiation Oncology, Biomarkers) for Journal of Cancer Treatment and Diagnosis, Reviewer for British Journal of Radiology and
CARO annual scientific meeting. His research experience includes various programs, contributions and participation in different countries for diverse fields of study.
Mohammed Y Almaghrabi, J Cancer Sci Ther 2017, 9:9(Suppl)
DOI: 10.4172/1948-5956-C1-111